香港股市 將在 3 小時 52 分鐘 開市

Helen of Troy Limited (HELE)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
117.45+0.89 (+0.76%)
收市:04:00PM EDT
117.74 +0.29 (+0.25%)
收市後: 05:26PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價116.56
開市115.73
買盤115.58 x 800
賣出價117.79 x 1200
今日波幅115.73 - 119.89
52 週波幅81.14 - 143.68
成交量582,064
平均成交量368,174
市值2.83B
Beta 值 (5 年,每月)0.68
市盈率 (最近 12 個月)19.97
每股盈利 (最近 12 個月)5.88
業績公佈日2023年10月04日
遠期股息及收益率無 (無)
除息日
1 年預測目標價159.60
  • Benzinga

    Read Why This Analyst Is Bullish On Beachbody & Helen Of Troy

    DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating on the shares of Beachbody Company Inc (NYSE: BODY). The company issued a press release reaffirming its 4Q22 guidance for revenue of $140 million - $150 million. In the analyst's model, the EBITDA loss in 2022 estimate is narrowed to $(37) million versus $(86) million in 2021. During a chat with the analyst, the CFO did say the company is aiming for positive EBITDA in 2023E. Feedback from the Coaches was that there was too much comp

  • Benzinga

    Helen Of Troy's Q3 Highlights: Earnings Beat, 10.6% Sales Decline, Job Cuts & More

    Helen Of Troy Ltd (NASDAQ: HELE) reported a third-quarter FY23 sales decline of 10.6% year-on-year to $558.6 million, beating the consensus of $552.89 million. Core business net sales decreased 10% Y/Y and 9.6% compared to Q3 FY21. The company attributed the sale decline primarily to a decrease from Organic business of $115.6 million, or 18.5%, reflecting lower consumer demand and shifts in consumer spending patterns. Total net sales revenue for the Home & Outdoor segment fell 7% Y/Y, Health & W

  • Benzinga

    This Analyst Is Bullish On Helen Of Troy - Read Why

    DA Davidson analyst Linda Bolton Weiser upgraded Helen Of Troy (NASDAQ: HELE) from Neutral to Buy and raised the price target from $115 to $126. The analyst said Helen should benefit from the severity of the flu season. As CDC data showed, this flu season has started out to be one of the severest in recent history, said the analyst. Incidence of flu symptoms reported by medical professionals hit a recent peak of 7.5% in the week ended November 27, 2022 and is still very high at 6.9%. Weiser note